Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ocriplasmin for inducing total posterior vitreous detachment in subjects with diabetic retinopathy; study terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Posterior Vitreous Detachment

Drugs mentioned

• ocriplasmin (ocriplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Diabetic Retinopathy, Posterior Vitreous Detachment | Phase 2 | Status: TERMINATED | Results posted: 2020-12-16